These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16969488)

  • 1. Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
    Bendardaf R; Algars A; Elzagheid A; Korkeila E; Ristamäki R; Lamlum H; Collan Y; Syrjänen K; Pyrhönen S
    Oncol Rep; 2006 Oct; 16(4):741-6. PubMed ID: 16969488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases.
    Pereira PA; Rubenthiran U; Kaneko M; Jothy S; Smith AJ
    Anticancer Res; 2001; 21(4A):2713-7. PubMed ID: 11724345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
    Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
    Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD44s expression in biliary tract cancers.
    Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN
    Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role and prognostic significance of CD44s expression in colorectal cancer.
    Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL
    Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
    Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A
    Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
    Bendardaf R; Buhmeida A; Ristamäki R; Syrjänen K; Pyrhönen S
    Scand J Gastroenterol; 2007 Dec; 42(12):1473-8. PubMed ID: 17852862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.
    Buhmeida A; Elzagheid A; Algars A; Collan Y; Syrjänen K; Pyrhönen S
    APMIS; 2008 Jan; 116(1):1-9. PubMed ID: 18254773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
    Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM
    J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.
    Sakai K; Kaku T; Kamura T; Kinukawa N; Amada S; Shigematsu T; Hirakawa T; Kobayashi H; Ariyoshi K; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):360-6. PubMed ID: 10053108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
    Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
    Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
    Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
    Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinicopathological factors and the correlation between the adhesion molecule CD44 variant 9 expression and pulmonary metastases from colorectal cancers.
    Goi T; Koneri K; Katayama K; Hirose K; Yamaguchi A
    Int Surg; 2002; 87(2):130-6. PubMed ID: 12222916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
    Kuncová J; Urban M; Mandys V
    APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.